Home > Healthcare > Drug Device Combination > Therapeutic Systems > Weight Loss and Obesity Management Market

Weight Loss and Obesity Management Market Share

Report ID: GMI9706
Published Date: May 2024
Report Format: PDF

Download Free Sample

Weight Loss and Obesity Management Market Share

The market for weight loss and obesity management is characterized by fragmentation due to the presence of numerous established and small-scale vendors worldwide offering variety of products and services targeting different aspects of weight loss and obesity management. These variety of products include drugs, surgical equipment, and fitness equipment, among others. The fragmentation of the market is further amplified by the diversity of consumer preferences, healthcare needs, and regulatory landscapes across different regions. Established market players possess significant financial resources for investment in research and development to develop and launch new obesity treatment products. On the other hand, smaller companies rely on low pricing strategies to compete with established players.

Weight Loss and Obesity Management Market Companies

Prominent players operating in the weight loss and obesity management industry include:

Allurion
Amgen Inc.
Boehringer Ingelheim International GmbH
Eisai Co., Ltd.
Equinox Inc.
FOUND
Herbalife International of America, Inc.
Johnson & Johnson Services Inc. (Ethicon Inc.)
Kellogg Co.
Lifetime Fitness Inc.
Medtronic plc
Novo Nordisk A/S
Nutrisystem, Inc.
OptiBiotix Online
PRISTYN CARE
Roman Health Ventures Inc.
Takeda Pharmaceutical Company Ltd.
Teleflex Inc.
VIVUS LLC.
WW International, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of weight loss and obesity management was reached USD 232.4 billion in 2023 and is anticipated to showcase about 8.6% CAGR from 2024 to 2032, driven by increasing prevalence of obesity and overweight.

The adult segment of the weight loss and obesity management market recorded USD 206.4 billion in 2023 and will grow rapidly through 2032, owing to high prevalence of obesity among adults.

North America weight loss and obesity management market accounted for 42.6% share in 2023 and is predicted to reach USD 199.4 billion by 2032, attributed to high prevalence of obesity and increasing awareness towards fitness activities.

Allurion, Amgen Inc, Boehringer Ingelheim International Gmbh, Eisai Co., Ltd, Equinox Inc, FOUND, Herbalife International of America, Inc, Johnson & Johnson Services Inc. (Ethicon Inc.), and Kellogg Co. among others.